These markers are also positive in other cancers such as prostate adenocarcinoma (Her2/erbB2, CK7 and GCDFP15) [33–35] and colon cancer (Her2/erbB2 and CEA) [34, 36, 37]. This evidence concerns the gene ERBB2 and malignant colon neoplasm.